ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 681,81
1,19%
DAX
18 001,60
0,54%
Brent Oil
83,05
-0,69%
Bitcoin
61 840,95
4,61%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Bio Techne Corporation (TECH)

  7. Bio Techne Corporation (TECH) Actualités

TECH Bio Techne Corporation

77,60
2,00 (2,65%)
Dernière mise à jour : 19:30:29
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Bio Techne Corporation TECH NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
2,00 2,65% 77,60 19:30:29
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
76,89 76,18 77,91 75,60
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202412:30PRNUSBIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
30/4/202413:00PRNUSBIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF..
29/4/202413:00PRNUSBIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO..
26/4/202413:00PRNUSBIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR..
23/4/202413:00PRNUSBIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST..
10/4/202413:00PRNUSBIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO..
08/4/202413:00PRNUSBIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS..
03/4/202413:00PRNUSBIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR..
01/4/202413:00PRNUSBIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR..
28/3/202414:00PRNUSBIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP..
22/3/202412:00PRNUSBIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR..
12/3/202412:00PRNUSBIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH..
11/3/202421:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202421:03EDGAR2Form 144 - Report of proposed sale of securities
06/3/202413:00PRNUSBIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL..
07/2/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/2/202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/2/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202412:30PRNUSBIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
29/1/202413:00PRNUSBIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW..
25/1/202413:00PRNUSLUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH..
24/1/202413:00PRNUSSCIENTISTS AT THE WCBP CONFERENCE HIGHLIGHT ADVANCEMENTS IN..
16/1/202413:00PRNUSBIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO..
08/1/202412:32EDGAR2Form 8-K - Current report
05/1/202413:00PRNUSBIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS..
04/1/202413:00PRNUSBIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING..
21/12/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202313:00PRNUSBIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN..
20/12/202313:00PRNUSBIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR..
15/12/202300:15EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
14/12/202313:00PRNUSLUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP..
27/11/202313:00PRNUSBIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI..
13/11/202313:00PRNUSBIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
07/11/202322:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202323:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202323:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202312:00PRNUSASURAGEN TO PRESENT NOVEL CLINICAL TESTING DATA AT AMP 2023..
31/10/202311:30EDGAR2Form 8-K - Current report
31/10/202311:30PRNUSBIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
30/10/202321:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
TECH
Bio Techne
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés